METTL1‐m7G‐EGFR/EFEMP1 axis promotes the bladder cancer development
Clinical and Translational Medicine2021Vol. 11(12), pp. e675–e675
Citations Over TimeTop 1% of 2021 papers
Xiaoling Ying, Bixia Liu, Zusen Yuan, Yapeng Huang, Cong Chen, Jiang Xu, Haiqing Zhang, Defeng Qi, Shulan Yang, Shuibin Lin, Junhang Luo, Weidong Ji
Abstract
Our findings demonstrate the oncogenic role of METTL1 and the pathological significance of the METTL1-m7 G-EGFR/EFEMP1 axis in the BC development, thus providing potential therapeutic targets for the BC treatment.
Related Papers
- → Enzyme-Instructed Assembly and Disassembly Processes for Targeting Downregulation in Cancer Cells(2017)146 cited
- → Downregulation of miR-140-3p is a Cause of Upregulation of Rhoa Protein in Bronchial Smooth Muscle of Murine Experimental Asthma(2021)7 cited
- → Downregulation of POLD4 in Calu6 cells results in G1-S blockage through suppression of the Akt-Skp2-p27 pathway(2014)8 cited
- → Downregulation of p21/WAF1 Expression by Thymidylate Synthase(2001)17 cited
- → Viral Infection and Abnormal Brain Development: A DNA Microarray Study(2007)1 cited